First- or Second-Line Subcutaneous Abatacept, Adalimumab, or Etanercept in patients with arthritis a comparison of Patient Characteristics, Healthcare Costs, and Biologic Persistence
Latest Information Update: 26 Aug 2015
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Aug 2015 New trial record